This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
Literatur
Arnold N, Hägele L, Walz L, Schempp W, Pfisterer J, Bauknecht T, Kiechle M (1996) Overrepresentation of 3q and 8q material and loss of 18q material are recurrent findings in advanced human ovarian cancer. Genes Chromosomes Cancer 16: 46–54
Caldes T, Perez-Segura P, Tosar A, De La Hoya M, Diaz-Rubio E (2000) Low frequency of microsatellite instability in sporadic breast cancer. Int J Oncol 16: 1235–1242
Cheng C-W, Wu P-E, Yu J-C, Huang C-S, Yue C-T, Wu C-W, Shen C-Y (2001) Mechanisms of inactivation of E-cadherin in breast carcinoma: modification of the two-hit hypothesis of tumor suppressor gene. Oncogene 20: 3814–3823
Chin K, De Solorzano CO, Knowles D et al. (2004) In situ analyses of genome instability in breast cancer. Nat Genet 36: 984–988
De Pinho RA, Polyak K (2004) Cancer chromosomes in crisis. Nat Genet 36: 932–934
Esteller M, Silva JM, Dominguez G et al. (2000) Promotor hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors. J Natl Cancer Inst 92: 564–569
Fearon ER, Vogelstein B (1990) A genetic model for colorectal tumorigenesis. Cell 61:759–767
Feinberg AP (2001) Cancer epigenetics takes center stage. Proc Natl Acad Sci USA 98: 392–394
Forozan F, Mahlamäki EH, Monni O et al. (2000) Comparative Genomic Hybridization analysis of 38 breast cancer cell lines: A basis for interpreting complementary DNA microarray data. Cancer Res 60:4519–4525
Graff JR, Gabrielson E, Fujii H, Baylin SB, Herman JG (2000) Methylation patterns of the E-cadherin 5′ CpG island are unstable and reflect the dynamic, heterogeneous loss of E-cadherin expression during metastatic progression. J Biol Chem 275: 2727–2732
Jain AN, Chin K, Boerresen-Dale AL, Erikstein BK, Lonning PE, Kaaresen R, Gray JW (2001) Quantitative analysis of chromosomal CGH in human breast tumors associates copy number abnormalities with p53 status and patient survival. Proc Natl Acad Sci USA 98: 7952–7957
Lin NU, Winer EP (2004). New targets for therapy in breast cancer: Small molecule tyrosine kinase inhibitors. Breast Cancer Res 6: 204–210
Loeb LA (2001) A mutator phenotype in cancer. Cancer Res 61: 3230–3239
Loveday RL, Greenman J, Simcox DL, Speirs V, Drew PJ, Monson JRT, Kerin MJ (2000) Genetic changes in breast cancer detected by comparative genomic hybridisation. Int J Cancer 86: 494–500
Miyoshi Y, Iwao K, Egawa C, Noguchi S (2001) Association of centrosomal kinase STK15/BTAK mRNA expression with chromosomal instability in human breast cancers. Int J Cancer 92: 370–373
Nathanson KL, Shugart YY, Omaruddin R, Szabo C, Goldgar D, Rebbeck TR, Weber BL (2002). CGH-targeted linkage analysis reveals a possible BRCA1 modifier locus on chromosome 5q. Hum Mol Genet 11: 1327–1332
Nowell PC (1989) The clonal nature of neoplasia. Cancer Cells 1: 29–30
Peltomaki P (2001) Deficient DNA mismatch repair: a common etiologic factor for colon cancer. Hum Mol Genet 10: 735–740
Porter D, Lahti-Domenici J, Keshaviah A et al. (2003) Molecular markers in ductal carcinoma in situ of the breast. Mol Cancer Res 1: 362–75
Rennstam K, Ahlstedt-Soini M, Baldetorp B et al. (2003) Patterns of chromosomal imbalances defines subgroups of breast cancer with distinct clinical features and prognosis. A study of 305 tumors by comparative genomic hybridisation. Cancer Res 63: 8861–8868
Rice JC, Futscher BW (2000) Transcriptional repression of BRCA1 by aberrant cytosine methylation, histone hypoacetylation and chromatin condensation of the BRCA1 promoter. Nucleic Acids Res 28:3233–3239
Roskoski R (2004) The ErbB/HER receptor protein tyrosine kinases and cancer. Biochem Biophys Res Commun 319: 1–11
Rummukainen J, Kytola S, Karhu R, Farnebo F, Larsson C, Isola JJ (2001) Aberrations of chromosome 8 in 16 breast cancer cell lines by comparative genomic hybridisation, fluorescence in situ hybridization, and spectral karyotyping. Cancer Genet Cytogenet 126: 1–7
Russo G, Zegar C, Giordano A (2003) Advantages and limitations of microarray technology in human cancer. Oncogene 22: 6497–6507
Simon R, Nocito A, Hübscher T et al. (2001) Patterns of HER-2/neu amplification and overexpression in primary and metastatic breast cancer. J Natl Cancer Inst 93: 1141–1146
Sorlie T, Tibshirani R, Parker J et al. (2003) Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci USA 100: 8418–8423
Tanner M, Järvinen P, Isola J (2001) Amplification of HER-2/neu and Topoisomerase-IIa in primary and metastatic breast cancer. Cancer Res 61: 5345–5348
Teixeira MR, Tsarouha H, Kraggerud SM et al. (2001) Evaluation of breast cancer polyclonality by combined chromosome banding and comparative genomic hybridisation analysis. Neoplasia 3: 204–214
Tomlinson IPM (2001) Mutations in normal breast tissue and breast tumors. Breast Cancer Res 3: 299–303
Veer van’t LJ, Dai H, Vijver van de MJ, He YD et al. (2002) Gene expression profiling predicts clinical outcome of breast cancer. Nature 31:530–536
Wang ZC, Lin M, Wei LJ et al (2004) Loss of heterozygosity and its correlation with expression profiles in subclasses of invasive breast cancers. Cancer Res 64: 64–71
Weimer J, Kiechle M, Arnold N (2000) FISH-microdissection (FISH-MD) analysis of complex chromosome rearrangements. Cytogenet Cell Genet 88: 114–118
Xu X, Brodie SG, Yang X et al. (2000) Haploid loss of the tumor suppressor Smad4/Dpc4 initiates gastric polyposis and cancer in mice. Oncogene 19: 1868–1874
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer Medizin Verlag Heidelberg
About this chapter
Cite this chapter
Arnold, N. (2006). Genetische Veränderungen des sporadischen Mammakarzinoms. In: Management des Mammakarzinoms. Onkologie aktuell. Springer, Berlin, Heidelberg . https://doi.org/10.1007/978-3-540-31748-7_16
Download citation
DOI: https://doi.org/10.1007/978-3-540-31748-7_16
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-31747-0
Online ISBN: 978-3-540-31748-7
eBook Packages: Medicine (German Language)